Description: EMV Capital plc is a venture capital firm specializing in seed, growth capital, early and mid stage investments. The firm focuses to invest in sustainability, life science, technology, transformative biomedical, deep tech, semiconductors, industrials, robotics, AI and healthcare technologies focusing on digital health, diagnostics, and therapeutics sectors. It also prefers to invest in companies that significantly improve the health and well-being of people with chronic diseases. Within digital health it focuses on data analytics, wearable technologies, and devices. The firm seeks to invest in companies based in European developed markets, United Kingdom and in the United States. It typically invests up to £15 million ($20.32 million), but may consider larger amounts. It prefers to hold a controlling interest in all principal subsidiaries. The firm prefers to invest through its balance sheet investments. EMV Capital plc was founded in 2008 and is based in London, United Kingdom with additional office in Beaconsfield, United Kingdom.
Home Page: www.emvcapital.com
20 St. Andrew Street
London,
EC4A 3AG
United Kingdom
Phone:
44 (0) 20 3011 2234
Officers
| Name | Title |
|---|---|
| Dr. Ilian Petkov Iliev Ph.D. | CEO & Executive Director |
| Mr. Edward Benjamin Peter Hooper | Executive Director, General Counsel & Group Company Secretary |
| Mr. Stephen Daniel Crowe | Chief Financial Officer |
| Ms. Kim Looringh-van Beeck | Head of Comms & Marketing |
| Mr. Harry Miller | Head of Research |
| Mr. Nick Salisbury | Head of Capital Raising & Co-Investment |
| Ms. Hannah Jarvis | Financial Controller |
| Mr. Andy Maylor | Investment & Advisory Associate |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.5826 |
| Price-to-Sales TTM: | 7.9163 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 29 |